Abstract
Immunology, in all its facets of immunochemistry, humoral immunity, cellular immunity, immunodiagnosis, and immunotherapy, is currently the most rapidly advancing discipline of clinical and experimental oncology. But as in most developing subjects, it is continually beset with problems of methodology and nomenclature, both of which are often intertwined. Indicative of this problem are our circular definitions of antigen and antibody. Another frequent problem is the use of the words “specific” and “associated” when characterizing reactions to tumors or the antigenic properties of neoplasms. When applied to cancer, these terms are obviously very dependent upon the methods used to demonstrate these qualities. Indeed, the very diverse nature and multitude of types of cancer preclude our making generalizations or categorical statements regarding tumor “specificity.” Similar problems arise when one considers that many antigens found in malignant tumors share certain properties with embryonic or fetal tissues. First, these observations emphasize a lack of true tumor specificity, for which reason the category of oncofetal antigens has been established. Second, whether or not such antigens are truly oncofetal depends upon the method of detection used, and it has been found that here too specificity decreases as the antigen assay increases in sensitivity. Thus, whether substances can be truly oncofetal in nature still remains a matter of debate, and such terms must therefore be used in an operational sense. The words of Aldous Huxley (1924) during his travels “Along the Road” appropriately express these relationships:
“Most of our mistakes are fundamentally grammatical. We create our own difficulties by employing an inadequate language to describe facts. Thus, to take one example, we are constantly giving the same name to more than one thing, and more than one name to the same thing. The results, when we come to argue, are deplorable. For we are using a language which does not adequately describe the things about which we are arguing.”
Some of the author’s investigations discussed in this paper were supported by U.S. Public Health Service Grants CA-15799 and CA-17742 from the National Cancer Institute.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abelev, G.I.: Production of embryonal serum α-globulin by hepatomas: Review of experimental and clinical data. Cancer Res. 28, 1344–1350 (1968).
Abelev, G.I.: Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Advanc. Cancer Res. 14, 295–358 (1971).
Abelev, G.I.: Alpha-fetoprotein production by normal liver and liver tumors. In: Protides of the Biological Fluids (ed. H. Peeters), pp. 203–209. Oxford: Pergamon Press 1971.
Abelev, G.I., Alpert, E., Hull, E.W., Masseyeff, R., De Nechaud, B., Tatarinov, Y., Uriel, J.: Les protéines sériques foeto-spécifiques. Recommandations en vue d’une normalisation de la terminologie. Bull. Org. mond. Santé 43, 311–312 (1970).
Abelev, G.I., Perova, S.D., Khramkova, N.I., Postnikova, Z.A., Irlin, I.S.: Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1, 174–180 (1963).
Abelev, G.I., Tsvetkov, V.S., Biryulina, T.I., Él’gort, D.A., Olovnikov, A.M., Gusev, A.I., Yazova, A.K., Perova, S.D., Rubtsov, I. V., Shaborina, S. V., Kantorovich, B.A., Tur, V.M., Khazanov, A.I., Levina, D.M.: Value of highly sensitive methods of α-fetoprotein determination for the diagnosis of hepatocellular cancer and teratoblastoma (in Russian). Bull. exp. Biol. Med. 4, 75–81 (1971).
Adinolfi, M., Gardner, B., Martin, W.: Fetal proteins and immunoglobulins in Down’s syndrome. Atti. Assoc. Genet. ital. 12, 133–143 (1967).
Akai, S., Kato, K: Serum alpha-fetoprotein-positive stomach cancer. Gann Monogr. on Cancer Res. 14, 149–154(1973).
Akeyama, T., Koyama, T., Kamada, T.: Alpha-fetoprotein in acute viral hepatitis. New Engl. J. Med. 287, 989 (1972).
Alexander, P.: Foetal “antigens” in cancer. Nature (Lond.) 235, 137–140 (1972).
Alpert, E., Drysdale, J. W., Isselbacher, K.J.: Isoelectric focusing of human α-fetoprotein: An aid in purification and characterization of microheterogeneity. Ann. N.Y. Acad. Sci. 209, 387–396 (1973).
Alpert, E., Drysdale, J.W., Isselbacher, K.J., Schur, P.H.: Human a-fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J. biol. Chem. 247, 3792–3798 (1972).
Alpert, E., Hershberg, R., Schur, P.H., Isselbacher, K.J.: α-Fetoprotein in human hepatoma: Improved detection in serum and quantitative studies using a new sensitive technique. Gastroenterology 61, 137–143 (1971a).
Alpert, E., Pinn, V.W., Isselbacher, K.J.: Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver. New Engl. J. Med. 285, 1058–1059 (1971b).
Alpert, E., Starzl, T.E., Schur, P.H., Isselbacher; Serum alpha-fetoprotein in hepatoma patients after liver transplantation. Gastroenterology 61. 144–148 (1971c).
Alpert, E., Zuckerman, J.: Absence of alpha-1-fetoprotein antigen or antibody in maternal sera. Lancet 1970 II, 465.
Banjo, C., Gold, P., Freedman, S.O., Krupey, J.: Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system. Nature New Biol. (Lond.) 238, 183–185 (1972).
Banjo, C., Gold, P., Gehrke, C.W., Freedman, S.O., Krupey, J.: Preparation and isolation of immunologically active glycopeptides from carcinoembryonic antigen (CEA). Int. J. Cancer 13, 151–163 (1974a).
Banjo, C., Shuster, J., Gold, P.: Intermolecular heterogeneity of the carcinoembryonic antigen. Cancer Res. 34. 2114–2121 (1974b).
Banwo, O., Versey, J., Hobbs, J.R.: New oncofetal antigen from human pancreas. Lancet 1974 I, 643–645.
Baur, S., Roitt, I.M., Doniach, D.: Characterization of the human gastric parietal cell auto-antigen. Immunology 8. 62–68 (1965).
Becker, F.F., Sell, S.: Early elevation of alpha1 -fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis. Cancer Res. 53, 289–291 (1974).
Bergstrand, C.G., Czar, B.: Demonstration of a new protein fraction in serum from human fetus. Scand. J. clin. Lab. Invest. 8, 174 (1956).
Bernades, P.: Alpha-l-foeto-protéine et cancers digestifs primitifs en dehors de l’hépatome. Ann. Gastroent. Hépatol. 7, 565–570 (1971).
Bernades, P., Smadja, M., Rueff, B., Bonnefond, A., Tursz, T., Martin, E., Bognel, C., Barge, J., Uriel, J.: Présence de l’alpha-foeto-protéine sérique dans quartre cas de cancers digestifs primitifs autres que l’hépatome. Presse méd. 79. 1585–1587 (1971).
Bierfield, J.L., Scheiner, M.I., Schultz, D.R., Moral, M.D., Rogers, A.I.: Alpha-fetoprotein and carcinoembryonic antigen in a case of gastric carcinoma metastatic to the liver. Amer. J. dig. Dis. 18, 517–520 (1973).
Bivins, B.A., Meeker, W.R., jr., Griffen, W.O., jr.: Carcinoembryonic antigen levels and tumor histology in colon cancer. J. Surg. Res. 18. 257–261 (1975).
Blair, O.M., Goldenberg, D.M.: A correlative study of bronchial cytology, bronchial washing carcinoembryonic antigen, and plasma carcinoembryonic antigen in the diagnosis of bronchogenic cancer. Acta cvtologica 18. 510–514 (1974).
Bloomer, J.R., Waldmann, T.A., McIntire, K.R., Klatskin, G.: Relationship of serum α-fetoprotein to the severity and duration of illness in patients with viral hepatitis. Gastroenterology 68, 342–350 (1975).
Booth, S.N., King, J.P.G., Leonard, J.C., Dykes, P. W.: Serum carcinoembryonic antigen in clinical disorders. Gut 14, 794–799 (1973).
Bordes, M., Michiels, R., Martin, F.: Detection by immunofluorescence of carcinoembryonic antigen in colonic carcinoma, other malignant or benign tumors, and non-cancerous tissues. Digestion 9, 106–115 (1973).
Boureille, J., Metayer, P., Sauger, F., Matray, F., Fondimare, A.: Existence d’alpha-foeto- protéine au cours d’un cancer secondaire du foie d’origine gastrique. Presse méd. 78, 1277–1278 (1970).
Breborowicz, J., Easty, G.C., Neville, A.M.: In-vitro production of carcinoembryonic antigen by normal and neoplastic colon. Lancet 1973 II, 1393.
Broberger, O., Perlmann, P.: Autoantibodies in human ulcerative colitis. J. exp. Med. 110, 657–674 (1959).
Bubenik, J., Perlmann, P., Helmstein, K., Moberger, G.: Immune response to urinary bladder tumors in man. Int. J. Cancer 5 39–46 (1970).
Buffe, D.: Fetoproteins and children’s tumours. Gann Monogr. on Cancer Res. 14, 117–128 (1973).
Buffe, D., Rimbaut, C.: L’α1-foetoprotéine dans les atteintes hépatiques et les maladies métaboliques de l’enfant. Biomed. 19, 172–176 (1973).
Buffe, D., Rimbaut, C., Fuccaro, C., Burtin, P.: Isolement et caractérisation d’une ferroprotéine tissulaire l’α2 H-globuline. Ann. Inst. Pasteur 123, 129–142 (1972).
Buffe, D., Rimbaut, C., Lemerle, J., Schweisguth, O., Burtin, P.: Présence d’une ferroprotéine d’origine tissulaire, l’α2 H, dans le sérum des enfants porteurs de tumeurs. Int. J. Cancer 5, 85–87 (1970).
Bull, L.M., Leibach, J.R., Williams, M.A., Helms, R.A.: Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration. Science 181, 957–959 (1973).
Burtin, P., Buffe, D., von Kleist, S., Wolff, E., Wolff, Et.: Mise en évidence de l’antigène carcinoembryonnaire spécifique des cancers digestifs dans les tumeurs humaines entretenues en culture organotypique. Int. J. Cancer 5, 88–95 (1970).
Burtin, P., Chavanel, G., Hirsch-Marie, H.: Characterization of a second normal antigen that cross-reacts with CEA. J. Immunol. 111, 1926–1928 (1973a).
Burtin, P., von Kleist, S., Buffe, D.: Etude sur les antigènes foetaux humaines. I. Étude immunoélectrophorétique des antigènes du sérum foetal humaine absents de sérum adulte. Bull. Soc. Chim. biol. (Paris) 49, 1389–1398 (1967).
Burtin, P., von Kleist, S., Sabine, M.C.: Loss of a normal colonic membrane antigen in human cancers of the colon. Cancer Res. 31, 1038–1041 (1971).
Burtin, P., von Kleist, S., Sabine, M.C., King, M.: Immunohistological localization of carcinoembryonic antigen and nonspecific crossreacting antigen in gastrointestinal normal and tumoral tissues. Cancer Res. 33, 3299–3305 (1973b).
Burtin, P., Martin, E., Sabine, M.C., von Kleist, S.: Immunological study of polyps of the colon. J. nat. Cancer Inst. 48, 25–32 (1972a).
Burtin, P., Quan, P.C., Sabine, M.C.: Nonspecific cross reacting antigen as a marker for human polymorphs, macrophages and monocytes. Nature (Lond.) 255, 714–716 (1975).
Burtin, P., Sabine, M.C., Chavanel, G.: Presence of carcinoembryonic antigen in children’s colonic mucosa. Int. J. Cancer 10, 72–76 (1972b).
Buttle, G.A.H., Eperon, J.L., Kovacs, E.: An antigen in malignant and in embryonic tissues. Nature (Lond.) 194, 780 (1962).
Chayvialle, J.A., Ganguli, P.C.: Radioimmunoassay of Alpha-fetoprotein in human plasma. Lancet 1973 I. 1355–1357.
Chism, S.E., Order, S.E., Heilman, S.: Tumor-fetal antigens in Hodgkin’s disease and immunoelectrophoresis analysis. Amer. J. Roentgenol. 117, 5–11 (1973).
Chu, T.M., Reynoso, G., Hansen, H.J.: Demonstration of carcinoembryonic antigen in normal human plasma. Nature (Lond.) 238, 152–153 (1972).
Coligan, J.E., Henkart, P.A., Todd, C.W., Terry, W.D.: Heterogeneity of the carcinoembryonic antigen. Immunochemistry 10, 591–600 (1973).
Coligan, J.E., Lautenschleger, J.T., Egan, M.L., Todd, C.W.: Isolation and characterization of carcinoembryonic antigen. Immunochemistry 9, 377–386 (1972).
Coligan, J.E., Todd, C.W.: Structural studies on carcinoembryonic antigen. Periodate oxidation. Biochem. 14. 805–810 (1975).
Collatz, E., von Kleist, S., Burtin, P.: Further investigations of circulating antibodies in colon cancer patients: On the autoantigenicity of carcinoembryonic antigen. Int. J. Cancer 8, 298–303 (1971).
Constanza, M.E., Nathanson, L.: Carcinofetal antigens. Progr. Clin. Immunol. 2, 191–224 (1974).
Constanza, M.E., Pinn, V., Schwartz, R.S., Nathanson, L.: Carcinoembryonic antigenantibody complexes in a patient with carcinoma and nephrotic syndrome. New Engl. J. Med. 289, 520–522 (1973).
Cooper, A.G., Brown, M.C., Kirch, M.E., Rule, A.H.: Relationship of carcinoembryonic antigen to blood substances A and i: Evidence that the antigenic sites are on different molecules. J. Immunol. 113, 1246–1251 (1974).
Couser, W.G., Wagonfeld, J.B., Spargo, B.H., Lewis, E.J.: Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Amer. J. Med. 57, 962–970 (1974).
Darcy, D.A., Turberville, C., James, R.: Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein. Brit. J. Cancer 28, 147–160 (1973).
Dattwyler, R.J., Murgita, R.A., Tomasi, T.B.: Binding of α-fetoprotein to murine T cells. Nature (Lond.) 256, 656–657 (1975).
Day, E.D.: The Immunochemistry of Cancer. Springfield, Ill.: Charles C Thomas 1965.
DeBoer, W.G.R.M., Forsyth, A., Nairn, R.C.: Gastric antigens in health and disease: Behaviour in early development, senescence, metaplasia and cancer. Brit. med. J. 1969 III, 93–94.
Denk, R., Tappeiner, G., Eckerstorfer, R., Holzner, J.H.: Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int. J. Cancer 10, 262–272 (1972).
Deutsch, E., Apffel, C.A., Mori, H., Walker, J.E.: A tumor-associated antigen in gastric cancer secretions. Cancer Res. 33, 112–116 (1973).
Dhar, P., Moore, T., Zamcheck, N., Kupchik, H.Z.: Carcinoembryonic antigen in colonic cancer. Use in preoperative diagnosis and prognosis. J. Amer. med. Ass. 221, 31–35 (1972).
Dukes, C.E.: The classification of cancer of the rectum. J. Path. Bact. 35, 323–332 (1932).
Dyce, B.J., Haverback, B.J.: Free and bound carcinoembryonic antigen in neoplasms and in normal adult and fetal tissue. Immunochemistry 11, 423–430 (1974).
Edgington, T.S., Astarita, R. W., Plow, E.F.: Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract. New Engl. J. Med. 293, 103–107 (1975).
Edynak, E.M., Old, L.J., Vrana, M., Lardis, M.P.: A fetal antigen associated with human neoplasia. New Engl. J. Med. 286, 1178–1183 (1972).
Egan, M.L., Coligan, J.E., Todd, C.W.: Radioimmune assay for the diagnosis of human cancer. Cancer 34, 1504–1509 (1974).
Egan, M.L., Todd, C.W.: Carcinoembryonic antigen: Synthesis by a continuous line of adenocarcinoma cells. J. nat. Cancer Inst. 48, 887–889 (1972).
Ehrlich, P.: Collected Studies on Immunity, translated by C. Boldman, pp. 441–442. New York: Wiley & Sons 1906.
Elgort, D.A., Abelev, G.I., Levina, D.M., Marienbach, E. V., Martochkina, G.A., Laskina, A. V., Solovjeva, E.A.: Immunoradioautography test for Alpha-fetoprotein in the differential diagnosis of germinogenic tumors of the testis and in the evaluation of effectiveness of their treatment. Int. J. Cancer 11, 586–594 (1973).
Embleton, M.J.: Significance of tumor associated antigens on human colonic carcinomata. Brit. J. Cancer 28 (Suppl. I), 142–152 (1973).
Endo, Y., Kanai, K., Iino, S., Oda, T.: Clinical significance of Alpha-fetoprotein with special reference to primary cancer of the liver. Gann Monogr. on Cancer Res. 14, 67–78 (1973).
Engelhardt, N. V., Goussev, A.I., Shipova, L. Ja., Abelev, G.I.: Immunofluorescent study of Alpha-fetoprotein (afp) in liver and liver tumors. I. Technique of αfp localization in tissue sections. Int. J. Cancer 7, 198–206 (1971).
Eveleigh, J.W.: Heterogeneity of carcinoembryonic antigen. Cancer Res. 34, 2122–2124 (1974).
Feizi, T., Turberville, C., Westwood, J.H.: Blood-group precursors and cancer-related antigens. Lancet 1975 II. 391–393.
Feldman, J.M., Plonk, J.W.: Carcinoembryonic antigen and carcinoid tumors. Ann. Intern. Med. 83, 82–83 (1975).
Field, B., Mitchell, G., Garrett, W., Kerr, C.: Amniotic Alpha-fetoprotein levels and anencephaly. Lancet 1973 II, 798.
Fishman, W.H., Inglis, N.R., Green, S., Antiss, C.L., Ghosh, N.K., Reif, A.E., Rustigan, R., Krant, M.J., Stolbach, L.L.: Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature (Lond.) 219, 697–699 (1968).
Florin-Christensen, A., Arana, R.M.: Alpha1-fetoprotein and anti-alpha1-fetoprotein in acute viral hepatitis. Brit. med. J. 1973 II, 94–95.
Foley, E.J.: Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 13, 835–837 (1953).
Freed, D.L.J., Taylor, G.: Carcinoembryonic antigen in faeces. Brit. med. J. 1972 I. 85–87.
Fritsche, R., Mach, J.P.: Identification of a new oncofoetal antigen associated with several types of human carcinomas. Nature (Lond.) 258, 734–737 (1975).
Fuks, A., Banjo, C., Shuster, J., Freedman, S.O., Gold, P.: Carcinoembryonic antigen (CEA): Molecular biology and clinical significance. Biochim. biophys. Acta (Amst.) 417, 123–152 (1975).
Furth, R. van, Adinolfi, M.: In vitro synthesis of the foetal -globulin in man. Nature (Lond.) 222, 1296–1299 (1969).
Geddes, E.W., Falkson, G.: Malignant hepatoma in the Bantu. Cancer 25, 1271–1278 (1970).
Geffroy, Y., Boureille, J., Denis, P., Colin, R., Metayer, P.: Bilan d’une recherche systématique de 1’alpha-1-foetoprotéine dans 224 hépatopathies. Sem. Hôp. Paris 47, 1281–1285 (1971).
Geffroy, Y., Denis, P., Colin, R., Sauger, F., Matray, F., Fondimare, A.: Présence d’alpha- 1-foetoprotéine chez l’adulte au cours d’une hépatite virale traitée par corticothérapie. Presse méd. 78, 1107–1108 (1970).
Geffroy, Y., Metayer, P., Denis, P., Phillipe, J., Matray, F., Sauger, F., Laumonier, R., Duval, C.: Alpha-foeto-protéine et cancer secondaire du foie. Presse méd. 78, 1896 (1970).
Gibbs, N.M., French, L.W.: The colon mucus antibody. J. clin. Path. 24, 867–869 (1971).
Gitlin, D.: Sites of α-fetoprotein synthesis. New Engl. J. Med. 285, 1436–1437 (1971).
Gitlin, D., Boesman, M.D.: Serum α-fetoprotein, albumin, and γG-globulin in the human conceptus. J. clin. Invest. 45, 1826–1838 (1966).
Gitlin, D., Boesman, M.D.: Fetus-specific proteins in several mammals and their relation to human α-fetoprotein. Comp. Biochem. Physiol. 21, 327–336 (1967).
Gitlin, D., Perricelli, A., Gitlin, G.:, Synthesis of α-fetoprotein by liver, yolk sac and gastrointestinal tract of the human conceptus. Cancer Res. 32, 979–982 (1972).
Go, V.L.W., Ammon, H. V., Holtermuller, K.H., Krag, E., Phillips, S.F.: Quantification of carcinoembryonic antigen-like activities in normal human gastrointestinal secretions. Cancer 36, 2346–2350 (1975).
Gold, D.V., Miller, F.: Characterization of human colonic mucoprotein antigen. Immunochemistry 11, 369–375 (1974).
Gold, D., Miller, F.: Chemical and immunological differences between normal and tumoural colonic mucoprotein antigen. Nature (Lond.) 255. 85–87 (1975).
Gold, J.M., Banjo, C., Freedman, S.O., Gold, P.: Immunochemical studies of the intramolecular heterogeneity of the carcinoembryonic antigen (CEA) of human digestive system. J. Immunol. 111, 1872–1879 (1973).
Gold, J.M., Freedman, S.O., Gold, P.: Human anti-CEA antibodies detected by radioim- munoelectrophoresis. Nature New Biol. (Lond.) 239, 60–62 (1972).
Gold, J.M., Gold, P.: The blood group A-like site on the carcinoembryonic antigen. Cancer Res. 33, 2821–2824 (1973).
Gold, P.: Circulating antibodies against carcinoembryonic antigens of the human digestive system. Cancer 20. 1663–1667 (1967).
Gold, P.: Antigenic reversion in human cancer. Ann. Rev. Med. 22, 85–94 (1971).
Gold, P., Freedman, S.O.: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. exp. Med. 121, 439–462 (1965a).
Gold, P., Freedman, S.O.: Specific carcinoembryonic antigens of the human digestive system. J. exp. Med. 122, 467–481 (1965b).
Gold, P., Gold, M., Freedman, S.O.: Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res. 28, 1331–1334(1968).
Gold, P., Krupey, J., Ansari, H.: Position of the carcinoembryonic antigen of the human digestive system in ultrastructure of tumor cell surface. J. nat. Cancer Inst. 45, 219–225 (1970).
Gold, P., Thomson, D.M.P., Freedman, S.O.: Circulating carcinoembryonic antigens. Clin. Res. 12, 476 (1969).
Gold, P., Wilson, T., Romero, R., Shuster, J., Freedman, S.O.: Immunology and colonic cancer: Further evaluation of the radioimmunoassay for carcinoembryonic antigen of the human digestive system as an adjunct in cancer diagnosis. Dis. Colon. Rect. 16, 358–365 (1973).
Goldenberg, D.M., Hansen, H.J.: Carcinoembryonic antigen present in human colonic neoplasms serially propagated in hamsters. Science 175, 1117–1118 (1972a).
Goldenberg, D.M., Hansen, H.J.: GW-39: A human tumor - animal model for carcinoembryonic antigen (CEA). Proc. Amer. Ass. Cancer Res. 13, 80 (1972b).
Goldenberg, D.M., Pant, K.D.: Studies of carcinoembryonic antigen and other markers of a xenografted human colonic carcinoma, GW-39. In: Protides of the Biological Fluids (ed. H. Peeters), 24, in press (1976a).
Goldenberg, D.M., Pant, K.D.: Colonic cancer-associated antigens in a heterografted human tumor, GW-39. In: Onco-Developmental Gene Expression (eds. W.H. Fishman, S. Sell), in press (1976 b).
Goldenberg, D.M., Pant, K.D., Dahlman, H.L.: Antigens associated with normal and malignant gastrointestinal tissues. Cancer Res. 36, 3455–3463 (1976a).
Goldenberg, D.M., Pant, K.D., Dahlman, H.: A new oncofetal antigen associated with gastrointestinal cancer. Proc. Amer. Ass. Cancer Res. 17, 155 (1976b).
Goldenberg, D.M., Pavia, R.A., Hansen, H.J., Vandevoorde, J.P.: Synthesis of carcinoembryonic antigen in vitro. Nature New Biol. (Lond.) 239, 189–190 (1972).
Goldenberg, D.M., Pegram, C.A., Vazquez, Identification of a colon-specific antigen (CSA) in normal and neoplastic tissues. J. Immunol. 114, 1008–1013 (1975).
Goldenberg, D.M, Pietsch, Q.A, Nagell, J.R. van, jr.: Characterization and localization of carcinoembryonic antigen in a squamous cell carcinoma of the cervix. Gynecol. Oncol. in press (1976c).
Goldenberg, D.M., Preston, D.F., Primus, F.J., Hansen, H.J.: Photoscan localization of GW-39 tumors in hamsters using radiolabeled anti-carcinoembryonic antigen immunoglobulin G. Cancer Res. 34, 1–9 (1974).
Goldenberg, D.M., Sharkey, R.M., Primus, F.J.: Carcinoembryonic antigen in histopathology: Immunoperoxidase staining of conventional tissue sections. J. nat. Cancer Inst. 57, 11–22 (1976d).
Goldenberg, D.M., Tchilinguirian, N.G.O., Hansen, H.J., Vandevoorde, J.P.: Carcinoembryonic antigen present in meconium: The basis of a possible new diagnostic test of fetal distress. Amer. J. Obstet. Gynecol. 113, 66–69 (1972b).
Goldenberg, D.M., Witte, S., Elster, K.: GW-39: A new human tumor serially transplantable in the golden hamster. Transplantation 4, 760–763 (1966).
Greenwood, F.C., Hunter, W.M., Coloner, J.S.: The preparation of 131I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89, 114–123 (1963).
Grigor, K.M., Detre, S.I., Laurence, D.J.R., Stevens, U., Neville, A.M.: Comparison of plasma carcinoembryonic antigen and Alpha-fetoprotein in various tumours. Lancet 1975 II, 412.
Gross, L.: Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 3, 326–333 (1943).
Guinan, P., John, T., Sadoughi, N., Ablin, R.J., Bush, I.: Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma. J. Urol. (Baltimore) 111, 350–352 (1974).
Haddow, A.: Immunology of the cancer cell: Tumour-specific antigens. Brit. Med. Bull. 21, 133–139 (1965).
Häkkinen, I.P.T.: Immunological relationship of the carcinoembryonic antigen and the fetal sulforglycoprotein antigen. Immunochemistry 9. 1115–1119 (1972).
Häkkinen, I.P.T.: FSA - Foetal sulphoglycoprotein antigen associated with gastric cancer. Transplant. Rev. 20, 61–76 (1974).
Häkkinen, I.P.T., Jarvi, O., Gironroos, J.: Sulphoglycoprotein antigens in the human alimentary canal and gastric cancer. An immunohistochemical study. Int. J. Cancer 3, 572–581 (1968a).
Häkkinen, I.P.T., Korhonen, L.K., Saxen, L.: The time of appearance and distribution of sulphoglycoprotein antigens of the human foetal alimentary canal. Int. J. Cancer 3, 582–592 (1968b).
Hall, R.R., Laurence, D.J.R., Darcy, D., Stevens, U., James, R., Roberts, S., Neville, A.M.: Carcinoembryonic antigen in the urine of patients with urothelial carcinoma. Brit. Med. J. 1972 III, 609–611.
Halterman, R.H., Leventhal, B.G., Mann, D.L.: An acute-leukemia antigen: Correlation with clinical status. New Engl. J. Med. 287, 1272–1274 (1972).
Hammarström, S., Engvall, E., Johansson, B.G., Svensson, S., Sundblad, G., Goldstein, I.J.: Nature of the tumor-associated determinant(s) of carcinoembryonic antigen. Proc. nat. Acad. Sci (Wash.) 72, 1528–1532 (1975).
Hansen, H.J., Lance, K.P., Krupey, J.: Demonstration of an ion sensitive antigenic site on carcinoembryonic antigen using zirconyl phosphate. Clin. Res. 19, 143 (1971).
Hansen, H.J., Snyder, J.J., Miller, E., Vandevoorde, J. V, Miller, O.N., Hines, L.R., Burns, J.J.: Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Human Pathol. 4, 139–147 (1974).
Hara, M., Watanabe, S., Kitagawa, M., Yasutomi, M.: Detection of carcinoembryonic antigen in feces for the diagnosis of colonic rectal cancers. Amer. J. Proctol. 25, 67–76 (1974).
Harris, R., Viza, D., Todd, R., Phillips, J., Sugar, R., Jennison, R.F., Marriott, G., Gleeson, M.H.: Detection of human leukaemia associated antigens in leukaemic serum and normal embryos. Nature (Lond.) 233, 556–557 (1971).
Hellström, I., Hellström, K.E., Pierce, G.E., Bill, A.H.: Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc. nat. Acad. Sci. (Wash.) 60, 1231–1238 (1968).
Hellström, I., Hellström, K.E., Shepard, T.H.: Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium. Int. J. Cancer 6, 346–351 (1970).
Hellström, I., Hellström, K.E., Sjögren, H.O., Warner, G.A.: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer 7, 1–16 (1971).
Henry, C., Bernard, D., Depieds, R.: Étude biochimique et immunochimique des antigènes solubles de la muqueuse du gros intestin humain. I. Extraction et fractionnement. Ann. Inst. Pasteur 114, 395–416 (1968).
Hirai, H., Nishi, S., Watabe, H., Tsukada, Y.: Some chemical, experimental, and clinical investigations of α-fetoprotein. Gann Monogr. on Cancer Res. 14, 19–34 (1973).
Hirsch-Marie, H., Chavanel, G., Burtin, P.: Carcinoembryonic antigens (CEA) and non specific cross-reacting antigens in feces. Digestion 9, 193–198 (1973).
Hirszfeld, L., Halber, W., Laskowski, J.: Untersuchungen über die serologischen Eigenschaften der Gewebe. II. Mitteilung. Ueber serologische Eigenschaften der Neubildungen. Z. Immunitätsforsch. 64, 81–113 (1929).
Hirszfeld, L., Halber, W., Rosenblat, J.: Untersuchungen über Verwandtschaftsreaktionen zwischen Embryonal- und Krebsgewebe. II. Vorläufige Mitteilung: Menschenembryo und Menschenkrebs. Z. Immunitätsforsch. 75, 209–216 (1932).
Holburn, A.M., Mach, J.P., MacDonald, D., Newlands, M.: Studies of the association of the A, B and Lewis blood group antigens with carcinoembryonic antigen (CEA). Immunology 26, 831–843 (1974).
Hollinshead, A., Glew, D., Bunnag, B., Gold, P., Herberman, R.: Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. Lancet 1970 I, 1191–1195.
Hollinshead, A.C., McWright, C.G., Alford, T.C., Gold, P., Herberman, R.B.: Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold. Science 177, 887–889 (1972).
Holyoke, E.D., Chu, T.M., Murphy, G.P.: CEA as a monitor of gastrointestinal malignancy. Cancer 35, 830–836 (1975).
Holyoke, D., Reynoso, G., Chu, T.M.: Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Ann. Surg. 176, 559–564 (1972).
Hooglie, R.: Benign hepatomas and oral contraceptives. Lancet 1974 I. 630.
Houstek, J., Masopust, J., Kithier, K., Radl, J.: Hepatocellular carcinoma in association with a specific fetal α1-globulin fetoprotein. J. Pediat. 72, 186–193 (1968).
Huitric, E.: An ultrastructural study of the localization of the carcinoembryonic antigen in adenocarcinomas of the human colon. Ann. Immunol. (Inst. Pasteur) 124C, 603–608 (1973).
Huitric, E., Laumonier, R., Burtin, P., Kleist, S. von, Chavanel, G.: An optical and ultra-structural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa. Lab. Invest. 34, 97–107 (1976).
Hull, E.W., Carbone, P.P., Gitlin, D., O’Gara, R.W., Kelly, M.G.: α-Fetoprotein in monkeys with hepatoma. J. nat. Cancer Inst. 42, 1035–1044 (1969).
Hull, E.W., Carbone, P.P., Moertel, C.G., O’Conor, G.T.: Serum alpha-fetoprotein in the U.S.A. Lancet 1970 I, 779–780.
Huxley, A.: Along the Road. Notes and Essays of a Tourist, p. 139. New York: G.H. Doran Co. 1925.
Ichiki, A.T., Wenzel, K.L., Quirin, Y.P., Lange, R.D., Eveleigh, J.: Immunochemical studies of carcinoembryonic antigen (CEA) variants. Brit. J. Cancer 33, 273–278 (1976).
Ishiguro, T., Nishimura, T.: Radioimmunoassay of maternal Serum alpha-fetoprotein associated with pregnancy. Amer. J. Obstet. Gynecol. 116, 27–33 (1973).
Ishii, M.: Radioimmunoassay of α-fetoprotein. Gann Monogr. on Cancer Res. 14, 89–98 (1973).
Karitzky, D., Burtin, P.: Isolement de l’autoantigène, responsable de la formation d’autoanticorps chez les malades atteints de cancer gastrique. Eur. J. Biochem. 1, 411–418 (1967).
Karvountzis, G.G., Redeker, A.G.: Relation of Alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann. Intern. Med. 80, 156–160 (1974).
Kew, M.C., Purves, L.R., Bersohn, I.: Serum alpha-fetoprotein levels in acute viral hepatitis. Gut 14, 939–942 (1973).
Khasanov, A.I., Abelev, G.I., Perova, S.D., Polenko, V.K, Ryapsova, U.K., Shirenkova, O.: Vopr. Onkol (1971); cited by Abelev (1971).
Khoo, S.K., Mackay, I.R.: Carcinoembryonic antigen in serum in diseases of the liver and pancreas. J. clin. Path. 26, 470–475 (1973).
Khoo, S.K., Warner, N.L., Lie, J.T., Mackay, I.R.: Carcinoembryonic antigenic activity of tissue extracts: A quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs. Int. J. Cancer 11, 681–687 (1973).
Kithier, K., Masopust, Radi, J.: Fetal alpha-globulin of bovine serum differing from fetuin. Biochim. Biophys. Acta 160, 135–137 (1968).
Klavins, J. V., Mesa-Fejada, R., Weiss, M.: Human carcinoma antigens cross-reacting with anti-embryonic antibodies. Nature New Biol. (Lond.) 234, 153–154 (1971).
Klein, G., Clifford, P., Henle, G., Henle, W., Geering, G., Old, L.J.: EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int. J. Cancer 4, 416–421 (1969).
Kleist, S. von, Burtin P.: Localisation cellulaire d’un antigène embryonnaire de tumeurs coliques humaines. Int. J. Cancer 4, 874–879 (1969).
Kleist, S. von, Chavanel, G., Burtin, P.: Identification of an antigen from normal human tissue that cross-reacts with the carcinoembryonic antigen. Proc. nat. Acad. Sci. (Wash.) 69, 2492–2494 (1972).
Kobayashi, K.: Studies on the specific antigens of human gastric cancer. I. Tohoku J. Exp. Med. 63, 185–190 (1956).
Kobayashi, K.: Studies on the specific antigens of human gastric cancer. II. Tohoku J. Exp. Med. 63, 191–202 (1956).
Kozower, M., Gawaz, K.A., Miller, H.M., Kaplan, M.M.: Positive alpha-fetogolubulin in a case of gastric carcinoma. New Engl. J. Med. 285, 1059–1060 (1971).
Kroes, R., Williams, G., Weisburger, J.H.: Early appearance of serum α-fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3’-methyl- 4-dimethylamino-azobenzene. Cancer Res. 32, 1526–1532 (1972).
Krupey, J., Gold, P., Freedman, S.O.: Purification and characterisation of carcinoembryonic antigens of the human digestive system. Nature (Lond.) 215, 67–68 (1967).
Krupey, J., Gold, P., Freedman, S.O.: Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J. exp. Med. 128, 387–398 (1968).
Kupchik, H.Z., Zamcheck, N.: Carcinoembryonic antigen(s) in liver disease. II. Isolation from human cirrhotic liver and serum and from normal liver. Gastroenterology 63, 95–101 (1972).
Lacassagne, A.: Sur l’histogenèse des carcinomes hépatiques. A propos des foetoprotéines specifiques. Bull. Cancer 55, 181–204 (1968).
Laurence, D.J.R., Stevens, U., Bettelheim, R., Darcy, D., Lesse, C., Turberville, C., Alexander, P., Johns, E.W., Neville, A.M.: Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Brit. med. J. 1972 III, 605–609.
Lehmann, F.G.: Der Nachweis von α1-Fetoprotein bei internen Erkrankungen. Aktueller Stand des Problems. Internist 13, 332–339 (1972).
Lehmann, F.G., Lehmann, D.: Neue immunologische Techniken und quantitative Bestimmung von Alpha1-Fetoproteinen in der Tumordiagnostik. Verh. dtsch. Ges. inn. Med. 78, 841–845 (1972).
Lehmann, F.G., Lehmann, D.: Vergleich verschiedener Methoden zum serologischen Nachweis von α1-Foetoproteinen in der Tumordiagnostik. Verh. dtsch. Ges. inn. Med. (1973).
Lehmann, F.G., Lehmann, D., Martini, G.A.: α1-Foetoprotein in liver diseases. Digestion 6, 249–250 (1972).
Lejtenyi, M.C., Freedman, S.O., Gold, P.: Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system. Cancer 28, 115–120 (1971).
Levi, M.M., Keller, S., Maudl, I.: Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions. Amer. J. Obstet. Gynecol. 105, 856–861 (1969).
Linder, E., Seppälä, M.: Localization of α-foetoprotein in the human foetus and placenta. Acta path. microbiol. scand. 73, 565–571 (1968).
Livingstone, A.S., Hampson, L.G., Shuster, J., Gold, P., Hinchey, E.J.: Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma. Current status. Arch. Surg. 109, 259–264 (1974).
LoGerfo, P., Herter, F., Hansen, H.J.: Demonstration of tumor associated antigen in normal colon and lung. J. Surg. Oncol. 4, 1–7 (1972).
LoGerfo, P., Krupey, J., Hansen, H.J.: Demonstration of an antigen common to several varieties of neoplasia. New Engl. J. Med. 285, 138–141 (1971).
Lynraven, G.S., de Boer, W.G.R.M.: A specific antiserum for gastric mucous epithelium. Pathology 1, 57–60 (1969).
Mach, J.P., Jaeger, P., Berthelot, M.M., Ruegsegger, C.H., Loosli, R.M., Pettavel, J.: Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (CEA). Lancet 1974 II, 535–540.
Mach, J.P., Pusztaszeri, G.: Carcinoembryonic antigen (CEA): Demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry 9, 1031–1034 (1972).
Martin, E.W., jr., Kibbey, W.E., DiVecchia, L., Anderson, G., Catalano, P., Minton, J.P.: Carcinoembryonic antigen. Clinical and historical aspects. Cancer 37, 62–81 (1976).
Martin, F., Martin, M.S.: Demonstration of antigens related to colonic cancer in the human digestive system. Int. J. Cancer 6, 352–360 (1970).
Martin, F., Martin, M.S.: Radioimmunoassay of carcinoembryonic antigen in extracts of human colon and stomach. Int. J. Cancer 9, 641–647 (1972).
Masopust, J., Tomášová, H., Kotál, L.: Some physicochemical characteristics of human α1-fetoprotein. In: Protides of the Biological Fluids (ed. H. Peeters) 18, 37–42 (1971).
Masseyeff, R.: Human alpha-fetoprotein. Path. Biol. 20, 703–725 (1972).
Masseyeff R.F.: Factors influencing α-fetoprotein biosynthesis in patients with primary liver cancer and other diseases. Gann Monogr. on Cancer Res. 14, 3–18 (1973).
Masseyeff, R., Basteris, B., Leblanc, L.: Use of the Alpha-fetoprotein test for the diagnosis of primary liver cancer. In: Protides of the Biological Fluids (ed. H. Peeters) 18, 217–220 (1971).
Matray, F., Sauger, F., Borde, J., Mitrofanoff P., Grosley, M., Bourg, M., Laumonier, R., Hemet, J.: Présence d’alpha-foetoprotéine au cours d’une régénération hépatique après hépatectomie gauche pour hépatomie gauche pour hépatome chez un enfant. Path. Biol. 20, 353–356 (1972).
Mawas, C., Buffe, D., Burtin, P.: Influence of age on Alpha-fetoprotein incidence. Lancet 1970 I, 1292.
McCartney, W.H., Hoffer, P.B.: The value of carcinoembryonic antigen (CEA) as an adjunct to the radiological colon examination in the diagnosis of malignancy. Radiology 110, 325–328 (1974).
McConahey, P.J., Dixon, F.J.: A method of trace iodination of proteins for immunologic studies. Arch. Allergy Appl. Immunol. 29, 185–189 (1969).
McIntire, K.R., Vogel, C.L., Princier, G.L., Patel, I.R.: Serum α-fetoprotein as a biochemical marker for hepatocellular carcinoma. Cancer Res. 32. 1941–1946 (1972).
McIntire, K.R., Waldmann, T.A., Go, V.L.W., Moertel, C.G., Ravry, M.: Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and Alpha-fetoprotein (aFP) in neoplasms of the gastrointestinal tract. Ann. Clin. Lab. Sci. 4, 104–108 (1974a).
McIntire, K.R., Waldmann, T.A., Moertel, C.G., Go, V.L.W.: Serum α-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res. 35, 991–996 (1974b).
Meeker, W.R., jr., Kashmiri, R., Hunter, L.: Clinical evaluation of carcinoembryonic antigen test. Arch. Surg. 107, 266–274 (1973).
Mehlman, D.J., Bulkley, B.H., Wiernik, P.H.: Serum α-fetoglobulin with gastric and prostatic carcinomas. New Engl. J. Med. 285, 1060–1061 (1971).
Miller, A.B.: A joint National Cancer Institute of Canada/American Cancer Society investigation. A collaborative study of a test for carcinoembryonic antigen (CEA) in the sera of patients with carcinoma of the colon and rectum. Canad. Med. Ass. J. 107, 25–33 (1972).
Montplaisir, S., Rabin, B., Pelletier, M., Rose, N.R., Alpert, E.: Alpha1 -fetoprotein content of gastric carcinoma and hepatic metastases. Amer. J. dig. Dis. 18, 416–418 (1973).
Moore, T.L., Kupchik, H.Z., Marcon, N., Zamcheck, N.: Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders. Amer. J. dig. Dis. 16, 1–8 (1971).
Morris, J.E., Egan, M.L., Todd, C.W.: The binding of carcinoembryonic antigen by antibody and its fragments. Cancer Res. 35, 1804–1808 (1975).
Morton, D.L., Malmgren, R.A., Hall, W.T., Schidlovsky, G.: Immunologic and virus studies with human sarcomas. Surgery 66, 152–161 (1969).
Morton, D.L., Malmgren, R.A., Holmes, E.C., Ketcham, A.S.: Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64, 233–240 (1968).
Mukherji, B., Hirschaut, Y.: Evidence for fetal antigen in human sarcoma. Science 181, 440–442 (1973).
Mulcare, R., LoGerfo, P.: Tumor associated antigen in the chemotherapy of solid tumors. J. Surg. Oncol. 4, 407–417 (1972).
Munjal, D., Goldenberg, D.M.: Circulating and tumor levels of glucose phosphate isomerase and carcinoembryonic antigen in hamsters xenografted with the GW-39 human colonic tumor. In: Program and Abstracts of Third International Symposium on Detection and Prevention of Cancer, pp. 425–430 (1976).
Murgita, R.A., Tomasi, T.B., jr.: Suppression of the immune response by α-fetoprotein. I. The effect of mouse α-fetoprotein on the primary and secondary antibody response. J. exp. Med. 141, 269–286 (1975a).
Murgita, R.A., Tomasi, T.B., jr.: Suppression of the immune response by α-fetoprotein. II. The effect of mouse α-fetoprotein on mixed lymphocyte reactivity and mitogen-induced lymphocyte transformation. J. exp. Med. 141, 440–452 (1975b).
Murray, M.J., Thal, A.P.: The clinical significance of circulating pancreatic antibodies. Ann. Intern. Med. 53, 548–555 (1960).
Nagell, J.R. van, jr., Pietsch, Q.A., Goldenberg, D.M.: A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms. Cancer Res. 35. 1433–1437 (1975).
Nairn, R.C., Fothergill, J.E., McEntegart, M.G., Porteus, I.B.: Gastro-intestinal-specific antigen: An immunohistological and serological study. Brit. med. J. 1962a I, 1788–1790.
Nairn, R.C., Fothergill, J.E., McEntegart, M.G., Richmond, H.G.: Loss of gastro-intestinal- specific antigen in neoplasia. Brit. med. J. 1962b I, 1791–1793.
Nairn, R.C., Ghose, T., Tannenberg, A.E.G.: Kidney specific antigen deletion in human renal carcinomas. Brit. J. Cancer 20, 756–759 (1966).
Nathanson, L., Fishman, W.H.: New observations on the Reagen isoenzyme of alkaline phosphatase in cancer patients. Cancer 27, 1388–1397 (1971).
Nayak, N.C., Malaviya, A.N., Chawla, V., Chandra, R.K.: α-Fetoprotein in Indian childhood cirrhosis. Lancet 1972 I, 68–69.
Nery, R., Bullman, H., Barsoum, A.: Carcinoembryonic antigen of erythrocyte membranes. Nature New Biol. (Lond.) 246, 44–46 (1973).
Newman, E.S., Petras, S.E., Georgiadis, A., Hansen, H.J.: Interrelationship of CEA and colon carcinoma antigen-III. Cancer Res. 34, 2125–2130 (1974).
Nishi, S.: Isolation and characterization of a human fetal alpha-globulin from the sera of fetuses and a hepatoma patient. Cancer Res. 30, 2507–2513 (1970).
Nishi, S., Hirai, H.: Purification and chemical characterization of human alpha-fetoprotein. In: Protides of the Biological Fluids (ed. H. Peeters). 18, 43–47 (1971).
Nishi, S., Hirai, H.: Radioimmunoassay of α-fetoprotein in hepatoma, other liver diseases, and pregnancy. Gann Monogr. on Cancer Res. 14, 79–87 (1973).
Nishioka, M., Ibata, T., Miyazato, K., Okita, K., Hironaga, K., Fujita, T.: Immunofluorescence studies on α-fetoprotein in hepatoma tissue. Gann Monogr. on Cancer Res. 14, 205–218 (1973).
Nishioka, M., Ibata, T., Okita, K., Harada, T., Fujita, T.: Localization of α-fetoprotein in hepatoma tissues by immunofluorescence. Cancer Res. 32, 162–166 (1972).
Nishioka, M., Okamoto, Y., Shigeta, K., Hironaga, K, Fujita, T.: Further observations on Alpha-fetoprotein in the diagnosis of diseases of the digestive tract. Digestion 8, 396–406 (1973).
Norland, C.C., Maass, E.G., Kirsner, J.B.: Identification of colon carcinoma by immunofluorescent staining. Cancer 23, 730–739 (1969).
Nunez, E., Engelmann, F., Benassay, G., Jayle, M.F.: Identification et purification préliminaire de la foetoprotéine liant les oestrogènes dans le sérum de rats nouveau-nés. C.R. Acad. Sci. (Paris) 273, 242–245 (1971).
O’Conor, G.T., Tatarinov, Y.S., Abelev, G.I., Uriel, J.: A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 25, 1091–1098 (1970).
Ogra, S.S., Margita, R.A., Tomasi, T.B., jr.: Immunosuppressive activity of mouse amniotic fluid. Immunol. Commun. 3, 497–508 (1974).
Old, L.J., Boyse, E.A.: Immunology of experimental tumors. Ann. Rev. Med. 15, 167–186 (1964).
Ona, F. V., Zamcheck, N., Dhar, P., Moore, T., Kupchik, H.Z.: Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer. Cancer 31, 324–327 (1973).
Opolon, P., Hirsch-Marie, H., Gateau, P., Caroli, J.: Apparition de l’alpha-1-foetoprotéine circulante au cours de l’atrophie aiguë du foie. Ann. Med. Interne 124, 883–888 (1973).
Parker, C.W.: The immunotherapy of cancer. Pharmacol. Rev. 25, 325–342 (1973).
Pedersen, K.O.: Fetuin, a new globulin isolated from serum. Nature (Lond.) 154, 575–576 (1944).
Piard, A., Mabille, J.P., Putelat, R.: Syndrome paranéoplastique à manifestations multiples révélateur d’un hypernéphrome avec présence d’alpha-foetoprotéine. Sem. Hôp. Paris. 49, 341–346 (1973).
Pierce, G.B.: Differentiation of normal and malignant cells. Fed. Proc. 29, 1248–1254 (1970).
Pietsch, Q.A., Goldenberg, D.M.: Molecular size of carcinoembryonic antigen in the plasma of patients with malignant disease. J. nat. Cancer Inst. 53, 1201–1204 (1974).
Plow, E.F., Edgington, T.S.: Isolation and characterization of a homogenous isomeric species of carcinoembryonic antigen: CEA-S. Int. J. Cancer 15, 748–761 (1975).
Primus, F.J., Hansen, H.J., Goldenberg, D.M.: Altered metabolism of carcinoembryonic antigen in hamsters bearing GW-39 tumours. Nature (Lond.) 249, 837–838 (1974).
Primus, F.J., Wang, R.H., Cohen, E., Hansen, HJ., Goldenberg, D.M.: Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors. Cancer Res. 36, 2176–2181 (1976).
Primus, F.J., Wang, R.H., Goldenberg, D.M., Hansen, H.J.: Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Cancer Res. 33, 2977–2982 (1973).
Primus, F.J., Wang, R.H., Sharkey, R.M., Goldenberg, D.M.: Detection of carcinoembryonic antigen in tissue sections by immunoperoxidase. J. Immun. Methods 8, 267–276 (1975).
Purtilo, D.T., Yunis, E.J.: α-Fetoprotein. Its immunofluorescent localization in human fetal liver and hepatoma. Lab. Invest. 25, 291–294 (1971).
Purves, L.R., Bersohn, I., Geddes, E.W.: Serum alpha-fetoprotein and primary cancer of the liver in man. Cancer 25, 1261–1270 (1970).
Purves, L.R., Branch, W.R., Geddes, E.W., Manso, C., Portugal, M.: Serum α-fetoprotein. VII. The range of apparent serum values in normal people, pregnant women, and primary liver cancer high risk populations. Cancer 31, 578–587 (1973).
Purves, L.R., Macnab, M., Bersohn, I.: Fetoglobulin and primary liver cancer. Lancet 1968 11, 634.
Purves, L.R., Macnab, M., Geddes, E.W., Bersohn, I.: Serum alpha-fetoprotein and primary hepatic cancer. Lancet 1968 I, 921–922.
Purves, L.R., Manso, C., Torres, F.O.: Serum α-fetoprotein levels in people susceptible to primary cancer in Southern Africa. Gann Monogr. on Cancer Res. 14, 51–66 (1973).
Purves, L.R., Purves, M.: Serum α-fetoprotein. VI. The radioimmunoassay. Evidence for the presence of α-fetoprotein in the serum of normal people and pregnant women. S. Afr. Med. J. 46, 1290–1297 (1972).
Purves, L.R., van der Merwe, E., Bersohn, I.: Variants of α-fetoprotein. Lancet 1970 II, 464–465.
Pusztaszeri, G., Mach, J.P.: Carcinoembryonic antigen (CEA) in non-digestive cancerous and normal tissues. Immunochemistry 10, 197–204 (1973).
Pusztaszeri, G., Saravis, C.A., Zamcheck, N.: The zinc glycinate marker in human colon carcinoma. J. nat. Cancer Inst. 56, 275–278 (1976).
Rappp W., Aranson, S.B., Burtin, P., Grabar, P.; Constituents and antigens of normal human gastric mucosa as characterized by electrophoresis and immunoelectrophoresis in agar gel. J. Immunol. 92, 579–595 (1964).
Remacle-Bonnet, M., Depieds, R.: Study of the antigenic constituents of human colon connective tissue. Path. Biol. 22, 113–117 (1974).
Reynoso, G., Chu, T.M., Holyoke, D., Cohen, E., Nemoto, T., Wang, J.J., Chuang, J., Guinan, P., Murphy, G.P.: Carcinoembryonic antigen in patients with different cancers. J. Amer. med. Ass. 220, 361–365 (1972).
Rioche, M., Quelin, S., Aeck, I., Jacquesson, M., Basteris, B., Masseyeff, R.: Culture in vitro de cellules de cancer primitif de foie humaine. C.R. Acad. Sci. (Paris) 271, 1148–1151 (1970).
Rogalsky, V.Y.: Variations in carcinoembryonic antigen localization in tumors of the colon. J. nat. Cancer Inst. 54, 1061–1065 (1975).
Rogers, G.T., Searle, F., Bagshawe, K.D.: Heterogeneity of carcinoembryonic antigen and its fractionation by con A affinity chromatography. Nature (Lond.) 251, 519–521 (1974).
Rosai, J., Tillack, T.W., Marchesi, V.T.: Membrane antigens of human colonic carcinoma and non-tumoral colonic mucosa: Results obtained with a new isolation method. Int. J. Cancer, 10, 357–367 (1972).
Rosenthal, L., Palmer, J.L., Harris, J.A., Rawls, W.E., Tompkins, W.A.F.: Antibody-induced redistribution of CEA on the cell surface: Utilization in separation of CEA and isoantigen A. J. Immunol. 115, 1049–1053 (1975).
Rule, A.H., Goleski-Reilly, C.: Carcinoembryonic antigen (CEA): Separation of CEA-reacting molecules from tumor, fetal gut, meconium and normal colon. Immunol. Commun. 2, 213–226 (1973).
Rule, A.H., Goleski-Reilly, C., Sachar, D.B., Vandevoorde, J., Janowitz, H.D.: Circulating carcinoembryonic antigen (CEA): Relationship to clinical status of patients with inflammatory bowel disease. Gut 14, 880–884 (1973).
Ruoslahti, E., Salaspuro, M., Pihko, H., Andersson, L., Seppälä, M.: Serum α-fetoprotein: Diagnostic significance in liver disease. Brit. med. J. 393, 527–529 (1974).
Ruoslahti, E., Seppälä, M.: Studies of carcino-fetal proteins. Physical and chemical properties of human α-fetoprotein. Int. J. Cancer 7, 218–225 (1971).
Ruoslahti, E., Seppälä, M.: Studies of carcino-fetal proteins. III. Development of a radioimmunoassay for α-fetoprotein. Demonstration of α-fetoprotein in serum of healthy human adults. Int. J. Cancer 8, 374–383 (1971).
Ruoslahti, E., Seppälä, M.: Normal and increased α-fetoprotein in neoplastic and non-neoplastic liver disease. Lancet 1972 II, 278–279.
Ruoslahti, E., Seppälä, M., Pihko, H., Vuopio, P.: Studies of carcino-fetal proteins. II. Biochemical comparison of α-fetoprotein from human fetuses and patients with hepatocellular cancer. Int. J. Cancer 8, 283–288 (1971).
Ruoslahti, E., Seppälä, M., Rasanen, J.A., Vuopio, P., Helske, T.: Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver. Scand. J. Gastroent. 8, 197–202 (1973).
Ruoslahti, E., Seppälä, M., Vuopio, P., Saksela, E., Peltokallio, P.: Radioimmunoassay of α-fetoprotein in primary and secondary cancer of the liver. J. nat. Cancer Inst. 49, 623–650 (1972).
Sukarai, M., Miyaji, T.: α-Fetoprotein and the morphology of hepatoma in man. Gann. Monogr. on Cancer Res. 14, 185–198 (1973).
Sannela, J.J. : Antigenic Properties of Normal Human Intestinal Mucosa. Dissertation, University of Buffalo, pp. 1–34 (1957).
Sarrazin, A., Emerit, J., Bousquet, O., Lanoe, J.: Hémochromatose avec alpha-foetoprotéine positive, un nouveau cas. Nouv. Presse méd. 2, 2602 (1973).
Sasaki, K., Miyakawa, A., Mito, M., Kasai, Y.: Histology of hepatoma in man with regard to α-fetoprotein. Gann Monogr. on Cancer Res. 14, 199–203 (1973).
Sauger, F., Duval, C., Fondimare, A., Matray, F., Buffe, D.: Systematic analysis of alphafetoprotein in 5000 sera. Rev. Europ. Etud. Clin. Biol. 16, 471–473 (1971).
Schapira, F.: Foetal enzyme patterns in cancer tissues. Rev. Europ. Etud. Clin. Biol. 16, 205–208 (1971).
Seller, M., Singer, J.D., Coltart, T.M., Campbell, S.: Maternal Serum alpha-fetoprotein levels and prenatal diagnosis of neural tube defects. Lancet 1974 I, 428–429.
Seppälä, M., Bagshawe, K.D., Ruoslahti, E.: Radioimmunoassay of alpha-fetoprotein: A contribution ot the diagnosis of choriocarcinoma and hydatidiform mole. Int. J. Cancer 10, 478–481 (1972).
Seppälä, M., Ruoslahti, E.: Alpha-fetoprotein in abortion. Brit. med. J. 1972a III, 769–771.
Seppälä, M., Ruoslahti, E.: Radioimmunoassay of maternal Serum alpha-fetoprotein during pregnacy and delivery. Amer. J. Obstet. Gynec. 112, 208–212 (1972b).
Seppälä, M., Ruoslahti, E.: Alpha-fetoprotein in Rh-immunized pregnancies. Obstet. Gynec. 42, 701–706 (1973a).
Seppälä, M., Ruoslahti, E.: Alpha-fetoprotein: Physiology and pathology during pregnancy and application to antenatal diagnosis. J. Perinat. Med. 1, 104–113 (1973b).
Seppälä, M., Ruoslahti, E.; Alpha-fetoprotein in maternal serum: A new marker for detection of fetal distress and intrauterine death. Amer. J. Obstet. Gynec. 115, 48–52 (1973c).
Seppälä, M., Tallberg, T., Ehnholm, C.: Studies on embryo-specific proteins. Physiological characteristics of embryo-specific alpha-globulins. Ann. Med. Exp. Fenn. 45, 16–19 (1967).
Shearer, W.T., Turnbaugh, T.R., Coleman, W.E., Aach, R.D., Philpott, G.W., Parker, C.W.: Cytotoxicity with antibody-glucose oxidase conjugates specific for a human colonic cancer and carcinoembryonic antigen. Int. J. Cancer 14, 539–547 (1974).
Shikata, T., Sakakibara, K.: Relationship between α-fetoprotein and histological patterns of hepatoma, and localization of α-fetoprotein in hepatoma cells using the peroxidase antibody technique. Gann Monogr. on Cancer Res. 14, 269–277 (1973).
Shuster, J., Silverman, M., Gold, P.: Metabolism of human carcinoembryonic antigen in xenogeneic animals. Cancer Res. 33, 65–68 (1973).
Silver, H.K, Deneault, J., Gold, P., Thompson, W.G., Shuster, J., Freedman, S.O.: The dectection of α1-fetoprotein in patients with viral hepatitis. Cancer Res. 34, 244–247 (1974)
Skarin, A.T., Delwiche, R., Zamcheck, N., Lokich, J.J., Frei, E., III: Carcinoembryonic antigen: Clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer 33, 1239–1245 (1974).
Slade, B.: Antibodies to Alpha-fetoprotein cause foetal mortality in rabbits. Nature (Lond.) 246, 493 (1973).
Smith, J.A.: Alpha-fetoprotein: A possible factor necessary for normal development of the embryo. Lancet 1972 I, 851.
Smith, J.A., Francis, T.I., Edington, G.M., Williams, A.O.: Immunofluorescent localization of human Alpha-fetoprotein in fetal and neonatal livers and cultured cells from hepatocellular carcinoma. Brit. J. Cancer 25, 343–349 (1971).
Smith, J.B.: Occurrence of Alpha-fetoprotein in acute viral hepatitis. Int. J. Cancer 8, 421–424(1971).
Smith, J.B.: Alpha-fetoprotein: Occurrence in certain malignant diseases and review of clinical applications. Med. Clin. N. Amer. 54, 797–803 (1970).
Smith, J.B., O’Neill, R.T.: Fetal gut antigen: A substance in fetal gut and its relationship to gut carcinoma. Res. Commun. Chem. Path. Pharmacol. 2, 1–15 (1971).
Smith, J.B., Todd, D.: Foetoglobulin and primary liver cancer. Lancet 1968 II, 833.
Sorokin, J.J., Sugarbaker, P.H., Zamcheck, N., Pisick, M., Kupchik, H.Z., Moore, F.D.: Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence. J. Amer. Med. Ass. 228, 49–53 (1974).
Spiro, M.J., Spiro, R.G.: Composition of the peptide portion of fetuin. J. biol. Chem. 237, 1507–1510 (1962).
Spiro, R.G.: Studies of fetuin, a glycoprotein of fetal serum. I. Isolation, chemical composition, and physicochemical properties. J. biol. Chem. 235, 2860–2869 (1960).
Spragins, J., Hall, W.H., White, H.J.: Fetoprotein from esophageal squamous cell carcinoma. Ann. Int. Med. 77, 322–323 (1972).
Stonehill, E.H., Bendich, A.: Retrogenetic expression: The reappearance of embryonal antigens in cancer cells. Nature (Lond.) 228, 370–372 (1970).
Sugahara, K., Kashii, A., Kogure, H.: Serum alpha-fetoprotein and resection of primary hepatic cancer. Arch. Surg. 105. 63–65 (1973).
Takahashi, M., Kawaguchi, A., Kawamata, K., Yasuma, T.: α-Fetoprotein by the immuno-fluorescent antibody technique in primary liver carcinoma and its histopathological basis. Gann Monogr. on Cancer Res. 14, 219–230 (1973).
Takahashi, M., Kawaguchi, A., Yasuma, T., Tanaka, M., Kawamata, K.: α-Fetoprotein by immunodiffusion and fluorescence antibody methods and histopathology of hepatoma (in Japanese). Med. Postgrad. 9, 249–260 (1971).
Takahasi, A., Yashi, A., Anzai, T., Wada, T.: Presence of a unique serum protein in sera obtained from patients with neoplastic diseases and in embryonic and neonatal sera. Clin. Chim. Acta 17, 5–12 (1967).
Tal, C., Dishon, T., Gross, J.: The agglutination of tumor cells in vitro by sera from patients and pregnant women. Brit. J. Cancer 18, 111–119 (1964).
Tal, C., Halperin, M.: Presence of serologically distinct protein in serum of cancer patients and pregnant women; An attempt to develop a diagnostic cancer test. Isr. J. Med. Sci. 6, 708–716 (1970).
Tappeiner, G., Denk, H., Eckerstorfer, R., Holzner, J.H.: Vergleichende Untersuchungen über Auftreten und Lokalisation des carcinoembryonalen Antigens (CEA) und eines normalen perchlorsäureextrahierbaren Dickdarmschleimhautantigens (NC) in Carcinomen und Polypen des Dickdarmes. Virchows Arch. path. Anat. 360, 129–140 (1973).
Tatarinov, Y.S.: Finding of an embryospecific α-globulin in blood serum in a patient with primary hepatic cancer (in Russian). Vop. med. Khim. 10, 90–91 (1964).
Terry, W.D., Henkart, P.A., Coligan, J.E., Todd, C.W.: Structural studies of the major glycoprotein in preparations with carcinoembryonic antigen activity. J. exp. Med. 136, 200–204 (1972).
Terry, W.D., Henkart, P.A., Coligan, J.E., Todd, C.W.: Carcinoembryonic antigen: Characterization and clinical applications. Transplant. Rev. 20, 100–129 (1974).
Thompson, W.G., Gillies, R.R., Silvery H.K.B., Shuster, J., Freedman, S.O., Gold, P.: Carcinoembryonic antigen and alpha1-fetoprotein in ulcerative colitis and regional enteritis. Canad. Med. Ass. J. 110, 775–777 (1974).
Thomson, D.M.P., Krupey, J., Freedman, S.O., Gold, P.: The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc. nat. Acad. Sci. (Wash.) 64, 161–167 (1969).
Tillack, T. W., Rosai, J., Vervynck, D.J.: Immunologic studies of glycoprotein isolated from cell membranes of human lung carcinomas. J. nat. Cancer Inst. 52, 1059–1067 (1974).
Tom, B.H., Rutzky, L.P., Oyasu, R., Tomita, J.T., Goldenberg, D.M., Kahan, B.D.: Human colonic adenocarcinoma cells. II. Tumorigenic and organoid expression in vivo and in vitro. J. Nat. Cancer Inst. In press (1976).
Tompkins, W.A.F., Watrach, A.M, Schmale, J.D., Schultz, RM., Harris, J.A.: Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J. nat. Cancer Inst. 52, 1101–1110 (1974).
Trouillas, P.: Carcinofetal antigen in glial tumours. Lancet 1971 II, 552.
Turberville, C., Darcy, D.A., Laurence, D.J.R., Johns, E.W., Neville, A.M.: Studies on carcinoembryonic antigen (CEA) and a related glycoprotein CCEA-2. Preparation and chemical characterisation. Immunochemistry 10, 841–843 (1973).
Turner, M.D., Olivares, T.A., Harwell, L., Kleinman, M.S.: Further purification of perchlorate-soluble antigens from human colonic carcinomata. J. Immunol. 108, 1328–1339 (1972).
Uriel, J.: Transitory liver antigens and primary hepatoma in man and rat. Path. Biol. 17, 877–884 (1969).
Uriel, J.: Fetal characteristics of cancer. In: Cancer 3. A comprehensive Treatise. Biology of Tumors: Cellular Biology and Growth (ed. F.F. Becker), pp. 21–55. New York: Plenum Press 1975.
Uriel, J., Aussei, C., Bouillon, D., de Néchaud, B., Loisillier, F.: Localisation of rat liver α-fetoprotein by cell affinity labelling with tritiated oestrogens. Nature New Biol. (Lond.) 244, 190–192 (1973).
Uriel, J., de Néchaud, B.: La recherche d’α-foetoprotéine en pathologie humaine. Etat actuel de la question. Ann. Inst. Pasteur 122, 829–839 (1972).
Uriel, J., de Néchaud, B.: An outline of the physiopathology of rat α-fetoprotein. Gann Monogr. on Cancer Res. 14, 35–47 (1973).
Uriel, J., de Néchaud, B., Dupiers, M.: Estrogen-binding properties of rat, mouse, and human fetospecific serum proteins. Demonstration by immuno-autoradiographic methods. Biochem. Biophys. Res. Commun. 46, 1175–1180 (1972).
Uriel, J., Loisillier, F., Szekely, A.M., Bismuth, H.: Autoradiographic localization of intracellular Alpha-fetoprotein in primary liver cancer in man. Biomed. 21, 21–25 (1974).
Vogel, C.L., Primack, A., McIntire, K.R., Carbone, P.P., Anthony, P.P.: Serum alpha- fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations. Cancer 33, 959–964 (1974).
Wada, T., Anzai, T., Yachi, A.: Immunochemical studies of antigenic components common to carcinoma and fetus, and their diagnostic significance. With special reference to the connection with α-fetoprotein. Gann Monogr. on Cancer Res. 14, 157–166 (1973).
Waldmann, T.A., McIntire, K.R.: Serum alpha-fetoprotein levels in patients with ataxia telangiectasia. Lancet 1972 II, 1112–1115.
Weiler, E.: Antigenic differences between normal hamster kidney and stilboestrol induced kidney carcinoma: Complement fixation reactions with cytoplasmic particles. Brit. J. Cancer 10, 553–559 (1956).
Westwood, J.H., Bessell, E.M., Bukhari, M.A., Thomas, P., Walker, J.M.: Studies of the structure of the carcinoembryonic antigen - I. Some deductions on the basis of chemical degradations. Immunochemistry 11, 811–818 (1974).
Witebsky, E.: Zur serologischen Spezifität des Carcinomgewebes. Klin. Wochenschr. 2, 58–63 (1930).
Witebsky, E., Rose, N.L., Shulman, S.: Studies of normal and malignant tissue antigens. Cancer Res. 16, 831–841 (1956).
Yachi, A., Matsuura, Y., Carpenter, C.M., Hyde, L.: Immunochemical studies on human lung cancer antigens soluble in 50% saturated ammonium sulfate. J. nat. Cancer Inst. 40, 663–682 (1968).
Zamcheck, N.: The present status of CEA in diagnosis, prognosis, and evaluation of therapy. Cancer 36, 2460–2468 (1975).
Zawadzki, Z.A., Kraj, M.A.: Alpha-fetoprotein in hepatocellular disease and neoplastic disorders. Amer. J. Gastroent. 61, 45–52 (1974).
Zilber, L.A.: Study of tumor specificity of gastric cancer tissue. Ann. N.Y. Acad. Sci. 101, 264–270 (1962).
Zweibaum, A., Oriol, R., Dausset, J., Marcelli-Barge, A., Ropartz, C., Lanset, S.: Definition in man of a polymorphic system of the normal colonic secretions. Tissue Antigens 6, 121–128 (1975).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin-Heidelberg
About this paper
Cite this paper
Goldenberg, D.M. (1976). Oncofetal and Other Tumor-Associated Antigens of the Human Digestive System. In: Morson, B.C. (eds) Pathology of the Gastro-Intestinal Tract. Current Topics in Pathology, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66481-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-66481-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66483-0
Online ISBN: 978-3-642-66481-6
eBook Packages: Springer Book Archive